Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",42097,231,0.89 [0.58-1.39],0.6192680301001754
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",43553,329,1.19 [0.83-1.69],0.3495433681205824
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",43118,2283,1.21 [1.05-1.38],0.0070685470804689
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Candidiasis,43591,699,1.14 [0.89-1.47],0.2861635577860735
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,42260,5824,1.13 [1.04-1.24],0.0047482618572452
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),42466,5302,1.42 [1.30-1.55],1.702222036936986e-14
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,43174,2022,1.33 [1.15-1.54],0.0001001393659844
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,43438,144,2.03 [1.26-3.28],0.003866061779929
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,40178,1581,1.47 [1.24-1.73],4.60192102335932e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,38771,1762,1.76 [1.51-2.04],8.319715070367932e-14
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,38649,414,1.68 [1.23-2.29],0.0010525262748409
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,30576,3261,1.41 [1.26-1.57],2.570885512877477e-09
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,38401,641,2.40 [1.91-3.02],6.063005611781002e-14
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,43527,2375,1.29 [1.13-1.47],0.0002062672418229
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Mycoses,43718,826,1.09 [0.87-1.38],0.4371192403065757
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,42361,1526,1.24 [1.05-1.47],0.0108433188784887
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,43609,1743,1.31 [1.12-1.53],0.0007607559484475
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,41483,331,1.19 [0.83-1.70],0.3469420715446411
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,43812,77,0.76 [0.35-1.61],0.4690833211937301
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,43392,1526,1.35 [1.14-1.59],0.0004028073831851
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,43422,128,0.89 [0.50-1.60],0.699364859253518
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,43669,263,1.21 [0.81-1.82],0.3507603327294419
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",43639,233,1.37 [0.89-2.09],0.152153672304589
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,41520,685,1.33 [1.03-1.70],0.0277618458277487
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,41291,456,1.28 [0.94-1.74],0.1180157792932528
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,41318,166,2.21 [1.40-3.47],0.0006006148393294
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,43772,93,0.95 [0.48-1.89],0.890635817722326
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,43696,261,1.16 [0.77-1.73],0.4835503034678617
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Viral warts,43522,87,1.69 [0.87-3.30],0.1213755268418231
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],43551,116,0.76 [0.41-1.41],0.3821765538306972
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign lipomatous neoplasm,43313,497,0.98 [0.73-1.33],0.914661319921694
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,43663,102,1.42 [0.75-2.70],0.2851283794288707
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,43622,106,0.98 [0.51-1.87],0.9392417593940112
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,20061,102,0.65 [0.34-1.27],0.2079184443123028
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",43243,2427,1.06 [0.93-1.21],0.3953413094641046
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm of meninges,43787,98,0.73 [0.37-1.44],0.3618842527383343
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,43702,115,2.15 [1.24-3.73],0.0065924600986439
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,43768,180,1.16 [0.71-1.88],0.553647611072726
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm of ovary,23644,149,0.72 [0.41-1.25],0.2385465357826468
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,43769,617,1.24 [0.95-1.61],0.106826795079721
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm: Caecum,43778,504,1.08 [0.80-1.44],0.6145679637249002
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",43619,123,0.69 [0.38-1.25],0.2173026483954584
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm: Descending colon,43771,371,1.12 [0.80-1.58],0.5092107879747184
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm: Rectum,43694,590,1.08 [0.82-1.41],0.5885816511457911
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,43612,1073,1.11 [0.91-1.36],0.2937747186129423
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,43760,715,1.06 [0.83-1.36],0.6318277262980992
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Carcinoma in situ of breast,19191,120,0.55 [0.29-1.02],0.0594565953527783
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",19262,139,0.73 [0.41-1.32],0.2993245733229575
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",34914,93,0.74 [0.37-1.50],0.4066184001783933
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",34939,118,0.83 [0.44-1.54],0.5490332222331823
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",43723,203,0.61 [0.38-0.98],0.0422990873874468
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Haemangioma, any site",43724,198,0.61 [0.38-0.98],0.0404083733867115
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Leiomyoma of uterus,22843,501,1.04 [0.77-1.40],0.8052111932299759
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Lung cancer and mesothelioma,30410,581,0.94 [0.71-1.25],0.6765553866821263
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Lymphoid leukaemia,34911,90,0.73 [0.35-1.50],0.3902928206061502
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",35133,312,1.08 [0.73-1.58],0.7096788627469535
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",35152,331,0.80 [0.55-1.17],0.2522741865975065
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",19390,164,2.31 [1.41-3.77],0.0008387923746228
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",34959,138,0.67 [0.37-1.19],0.1705680235318195
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",34999,178,1.82 [1.12-2.94],0.0151286100272579
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",34997,176,0.95 [0.57-1.57],0.8338723791759993
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",19352,126,1.03 [0.57-1.87],0.9278486628347996
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",34980,159,1.14 [0.67-1.93],0.631124929853921
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",16741,1146,0.85 [0.70-1.04],0.1150401215943727
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",35013,192,1.08 [0.66-1.76],0.7519724660255712
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",34950,129,1.24 [0.69-2.22],0.4764452895557485
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,34994,173,0.68 [0.40-1.15],0.1476507437734487
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Melanocytic naevi,43480,347,1.16 [0.81-1.66],0.4075444501249746
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Melanocytic naevi of trunk,43747,152,1.68 [1.00-2.82],0.0487514671764495
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Melanoma in situ,34878,138,0.61 [0.34-1.09],0.0949393756322242
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",34981,160,0.79 [0.46-1.35],0.3933101849395397
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",35096,275,0.91 [0.60-1.37],0.6491345713425677
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",35222,401,0.73 [0.52-1.02],0.0674748526922576
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",34991,170,1.39 [0.83-2.30],0.2078638223719742
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Other benign neoplasms of skin,43509,272,0.88 [0.59-1.32],0.5386143281581417
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",36628,1807,1.08 [0.92-1.27],0.3273492267590836
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",36723,1902,1.07 [0.91-1.25],0.4045333875250241
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,43312,575,0.94 [0.71-1.24],0.6544734491260571
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,40674,146,3.14 [2.06-4.78],1.0539798547159945e-07
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,42861,124,1.34 [0.75-2.41],0.3206938499628298
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,42497,4818,1.20 [1.09-1.32],0.000126276433697
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,41381,79,1.31 [0.63-2.69],0.4690601235952174
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,43114,89,1.24 [0.62-2.46],0.5381066422233789
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,43020,2492,1.33 [1.17-1.52],1.4729392122775482e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,43018,2490,1.33 [1.17-1.51],1.61209694025186e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,40670,142,1.35 [0.78-2.32],0.2843581142932201
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,43265,1963,1.29 [1.11-1.49],0.0006417393912296
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,43217,192,1.64 [1.04-2.59],0.0317092825014004
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,42841,104,1.18 [0.62-2.25],0.6111628589623999
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,42842,105,0.78 [0.40-1.49],0.4442466741461358
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,43492,467,1.24 [0.92-1.67],0.1612693812133582
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,43636,92,1.54 [0.79-3.03],0.2047420003227917
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",43412,387,1.10 [0.79-1.54],0.5614161390230219
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,41476,174,1.31 [0.80-2.15],0.2769227696513663
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,34056,506,1.96 [1.50-2.56],9.44453620715074e-07
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,40853,191,0.86 [0.53-1.40],0.5471368538600887
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,40879,217,1.25 [0.80-1.94],0.3275257408790861
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,33645,95,1.05 [0.53-2.08],0.8935666902921884
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,40726,106,0.89 [0.46-1.71],0.7329413126286592
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,39782,390,1.32 [0.95-1.83],0.1023070801050425
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",43042,891,1.01 [0.81-1.25],0.948735890203717
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,42605,454,1.05 [0.78-1.43],0.747137755443654
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,42328,177,0.74 [0.45-1.22],0.2419410874004562
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,43233,2613,1.21 [1.07-1.38],0.0032012696060887
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,38254,2542,1.18 [1.03-1.34],0.014211932014582
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",33651,101,1.29 [0.67-2.48],0.4462505905307025
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",40464,136,0.87 [0.49-1.54],0.6417707734153199
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,34011,461,2.20 [1.69-2.86],4.153361625488921e-09
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,33652,102,0.78 [0.40-1.54],0.474767200103741
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,39452,5902,1.17 [1.07-1.27],0.0004549214542794
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,33879,329,1.09 [0.76-1.58],0.6324031939104457
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,34474,924,1.61 [1.31-1.98],7.4276961834078975e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,43680,530,1.84 [1.41-2.41],8.50676794461429e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,43363,213,4.05 [3.01-5.46],2.957419958391343e-20
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,33760,210,1.17 [0.74-1.86],0.4973601869984336
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",33653,103,1.30 [0.69-2.46],0.4148333321068247
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,42898,2570,1.11 [0.97-1.26],0.1272229285287477
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,33975,425,2.43 [1.86-3.17],8.199292830099182e-11
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,34005,455,3.81 [3.12-4.65],2.9170366936336822e-39
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",34601,1051,1.28 [1.05-1.57],0.0167988952254771
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,33732,182,1.54 [0.96-2.47],0.0705938836435634
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,43353,203,4.07 [3.01-5.51],1.002109731127037e-19
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,34565,1015,1.15 [0.94-1.42],0.1815475028947727
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,34351,801,0.93 [0.73-1.18],0.5526085970601684
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,39503,111,1.75 [0.97-3.17],0.062803839435227
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,41892,8342,1.17 [1.09-1.26],1.9500165367839112e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,40403,75,0.76 [0.35-1.64],0.4837799237864046
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,40426,98,0.55 [0.28-1.09],0.0869084208228715
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,43507,3259,1.00 [0.89-1.12],0.9661400667492294
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",43507,3253,1.00 [0.89-1.12],0.9559620654826076
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,40415,87,1.38 [0.70-2.72],0.3502218066839827
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,43232,2044,1.05 [0.90-1.21],0.5406389416556101
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",36166,2616,1.35 [1.19-1.53],2.82127210300564e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,43792,353,2.13 [1.56-2.91],2.2154574761067987e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,42273,122,0.97 [0.54-1.76],0.9247437101997384
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,41364,176,1.24 [0.76-2.03],0.3855162521123566
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,41429,241,0.60 [0.39-0.93],0.0219689052735552
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",33826,276,1.93 [1.36-2.76],0.0002617837530323
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,39887,263,1.40 [0.94-2.08],0.0975243750900419
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,3611,140,2.21 [1.33-3.66],0.002165488036658
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,3838,411,0.89 [0.65-1.22],0.46781732865072
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,39729,105,2.01 [1.09-3.69],0.0247972073555977
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,3549,79,7.12 [4.26-11.90],6.624076646370678e-14
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,42761,3137,1.03 [0.92-1.17],0.5703323937088711
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,42714,563,1.11 [0.85-1.46],0.4491677743728961
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,40002,610,1.24 [0.96-1.61],0.1040689261989439
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,34793,1243,1.41 [1.18-1.69],0.0001866467010653
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",43616,413,1.32 [0.96-1.82],0.0831863653411645
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),41917,276,1.10 [0.74-1.64],0.6231488390458494
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Angina pectoris,40089,1979,1.01 [0.87-1.17],0.899992044182172
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,42048,407,1.10 [0.79-1.52],0.5788249755728119
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,41736,95,1.62 [0.84-3.11],0.1472389055551673
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",41966,325,1.52 [1.07-2.16],0.0199846112179899
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,27198,3180,1.15 [1.03-1.30],0.0173627162280511
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,AV-block,37002,714,0.96 [0.75-1.24],0.7686659799881633
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",43713,695,1.15 [0.90-1.47],0.2770251141667934
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Cardiac arrest,24333,315,2.20 [1.60-3.01],1.0106438005043577e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,36575,287,1.43 [0.98-2.11],0.0668656888286058
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",36449,161,1.99 [1.23-3.22],0.0048673568156504
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,43808,76,0.99 [0.47-2.08],0.9742533917745136
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Conduction disorders,38045,1757,1.08 [0.93-1.27],0.3126175251074583
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,41555,3476,1.16 [1.04-1.30],0.0074446322119628
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,38364,12888,1.06 [1.00-1.13],0.0420456106258001
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,41484,447,1.29 [0.95-1.75],0.1079403858902311
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Endocarditis,36405,117,0.61 [0.33-1.14],0.1241338466384958
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",43464,1829,1.26 [1.09-1.47],0.002269084702234
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Hypertension,39897,11010,1.17 [1.10-1.25],1.060812457593057e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",39910,11023,1.18 [1.10-1.25],5.552035845042039e-07
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",43514,136,0.95 [0.54-1.67],0.8638241339670754
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",29207,320,2.45 [1.81-3.30],4.6711189493109296e-09
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,29055,168,4.49 [3.58-5.63],1.730604050299255e-38
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Hypotension,43573,1914,1.39 [1.20-1.60],1.2049022669574725e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,42281,181,1.18 [0.72-1.92],0.5048354834898152
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",41849,3739,1.11 [0.99-1.23],0.0660328002201798
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",43196,938,1.28 [1.04-1.58],0.0217630308763776
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,36896,608,1.22 [0.94-1.59],0.1358297093424986
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,43037,1419,1.23 [1.04-1.47],0.0171088115193908
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",39306,1196,1.34 [1.11-1.62],0.0023624424159374
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",43650,270,1.47 [0.99-2.17],0.0534926759035429
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",43761,521,1.00 [0.75-1.34],0.97783988783162
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Oesophageal varices,41126,89,0.94 [0.46-1.90],0.8602097199162362
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other aneurysm,41770,129,1.01 [0.56-1.82],0.9665234730353224
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,37005,717,1.17 [0.91-1.49],0.2225008041006859
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,41809,168,1.61 [0.99-2.63],0.0551881066591825
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,42035,394,1.49 [1.08-2.05],0.0143466185092961
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,36592,304,1.14 [0.78-1.67],0.4880335634235224
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other disorders of veins,41189,152,0.75 [0.44-1.29],0.2972768596455146
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,41121,84,1.04 [0.50-2.14],0.9236724579897688
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,41449,104,1.15 [0.60-2.19],0.6726043375552819
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,41259,222,0.99 [0.64-1.55],0.9711595044360696
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,37990,1702,1.31 [1.12-1.54],0.000625499843883
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,41751,92,2.27 [1.21-4.25],0.0103849948016794
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,42555,914,1.37 [1.11-1.69],0.0039176212732118
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,42772,600,1.89 [1.48-2.41],4.0624848484992073e-07
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",42349,1004,1.13 [0.92-1.39],0.2331274430849783
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,24577,559,1.18 [0.89-1.56],0.2616563255497083
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,42260,674,1.57 [1.23-2.01],0.0002612366075077
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),41613,576,1.07 [0.81-1.41],0.6186835538961543
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,42958,786,1.17 [0.93-1.48],0.1818070324986984
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,43691,1079,1.21 [0.99-1.47],0.0570579979274526
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,36870,582,1.15 [0.88-1.51],0.3108207589597453
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,42764,592,1.90 [1.48-2.43],3.7560271436059786e-07
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,41658,313,1.12 [0.77-1.63],0.5390006772888735
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",43175,1075,1.26 [1.04-1.54],0.020337205359957
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",43141,1140,1.26 [1.04-1.52],0.0195651574073373
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,42233,99,1.49 [0.78-2.83],0.2243236797087936
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,41770,130,1.59 [0.91-2.80],0.1048005823339595
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,42638,380,1.23 [0.88-1.71],0.2295705397476163
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,42050,432,0.97 [0.70-1.33],0.8307983413921298
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Varicose veins,41735,698,0.90 [0.70-1.16],0.406976719496063
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,41666,141,1.65 [0.98-2.77],0.0597617090001104
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,43418,1238,1.12 [0.93-1.35],0.2238617401118989
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",43608,611,0.93 [0.71-1.22],0.5975557402904234
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",38404,2413,1.02 [0.89-1.17],0.723952133722357
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,Any mental disorder,42717,6726,1.01 [0.93-1.09],0.8277305237123962
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",43530,715,0.89 [0.69-1.14],0.3605886362186898
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",38651,2660,1.17 [1.03-1.34],0.0139680858553777
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",36130,139,1.14 [0.65-2.00],0.6398956670000017
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,Smoking dependency,42900,2322,0.94 [0.82-1.08],0.3862960400573538
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",38752,2761,0.94 [0.82-1.07],0.3209561059270094
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,Vascular dementia,43007,210,0.91 [0.58-1.43],0.6973523067774009
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Alzheimer disease,43810,566,1.15 [0.88-1.50],0.3186423757753381
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",29698,100,0.84 [0.43-1.65],0.6201383952056453
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Bell's palsy,40802,137,1.38 [0.79-2.40],0.253157040505335
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,41511,846,0.84 [0.67-1.06],0.1349189554005835
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Cerebral cysts,43127,374,1.06 [0.75-1.49],0.7490991558353493
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,43675,525,1.15 [0.87-1.53],0.3273886085853558
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,42985,93,1.01 [0.51-2.00],0.9696940522539048
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,43784,109,0.53 [0.28-1.00],0.0515657022187016
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",42871,118,0.92 [0.50-1.69],0.7858799926351082
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Epilepsy,41209,475,0.81 [0.59-1.10],0.1772470645606594
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,43002,2268,1.22 [1.06-1.40],0.0050188462621862
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,43733,695,0.71 [0.55-0.91],0.0072535158052611
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,42820,4266,1.08 [0.97-1.19],0.1492523895982497
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Generalized epilepsy,43178,90,0.42 [0.21-0.86],0.0166202568421741
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Hemiplegia,43561,411,1.27 [0.93-1.75],0.1351256805108375
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Hydrocephalus,42856,103,1.27 [0.67-2.40],0.4680979784608737
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,43779,116,1.71 [0.96-3.06],0.0707619335573467
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,40794,129,0.51 [0.28-0.93],0.026928164345067
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,40795,130,0.83 [0.46-1.49],0.5223533641268956
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Memory loss,42763,200,1.08 [0.68-1.72],0.7425835592046117
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Migraine,41333,599,1.56 [1.20-2.03],0.0009412464436502
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",43692,543,1.54 [1.17-2.03],0.0020750588906737
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Motor neuron disease,29890,255,0.92 [0.60-1.41],0.7067793120689372
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,43520,186,1.06 [0.65-1.73],0.8250153381008908
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",42688,2023,0.98 [0.85-1.14],0.8126328998456925
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Neurological diseases,41305,6169,1.00 [0.92-1.09],0.9809503148660094
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,43201,309,1.01 [0.70-1.46],0.9655757702575352
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",41345,680,0.85 [0.66-1.10],0.2135773075151164
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",43685,493,1.18 [0.88-1.58],0.2711873751247176
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,35061,1088,1.07 [0.87-1.31],0.5233723044472589
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,42872,119,0.98 [0.53-1.80],0.949830151827103
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,42989,236,1.13 [0.74-1.73],0.5784095044574322
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,43286,248,0.82 [0.54-1.25],0.3571898956124537
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,40827,162,1.43 [0.86-2.37],0.1686262775899448
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other headache syndromes,40836,102,1.13 [0.59-2.18],0.7173476492350647
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other neurological diseases,43613,860,1.01 [0.81-1.27],0.9338033109675034
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other sleep disorders,41658,924,1.37 [1.11-1.70],0.0040251559632219
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Parkinson's disease,43766,407,0.66 [0.48-0.91],0.011766677146928
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,42848,95,0.88 [0.44-1.75],0.7096566993777575
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Restless leg syndrome,43808,109,0.76 [0.40-1.44],0.4058295308027388
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Sleep apnoea,43411,802,1.42 [1.13-1.78],0.0029361379228411
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,43275,83,1.06 [0.52-2.20],0.8660096153041936
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,43784,299,0.81 [0.55-1.19],0.2874927431485129
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,40751,86,0.80 [0.39-1.64],0.5396287355541829
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,43810,572,1.14 [0.87-1.49],0.341016835519916
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),42939,203,0.91 [0.58-1.44],0.6870119342198706
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,42860,160,1.24 [0.74-2.05],0.41274317753181
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,43120,660,0.90 [0.70-1.17],0.4462446017731045
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,43540,387,0.66 [0.47-0.93],0.0171527708528943
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,42102,93,1.06 [0.54-2.10],0.8592351984563821
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,42107,98,1.04 [0.53-2.05],0.8996847699259473
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",43623,92,0.73 [0.37-1.46],0.3800622340961999
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,43370,245,0.84 [0.55-1.28],0.4244492674014627
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",3556,85,7.39 [4.53-12.08],1.3863676098827612e-15
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,4292,164,1.99 [1.27-3.12],0.0027191706523101
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,42864,164,1.37 [0.82-2.26],0.2255268194341518
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,43471,1747,0.88 [0.75-1.03],0.1153622934504814
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",43182,1173,1.00 [0.83-1.21],0.9925258521281166
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,42384,375,0.84 [0.60-1.18],0.3149798741420966
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",43673,1213,1.00 [0.83-1.21],0.9985111901392786
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,43798,117,1.36 [0.75-2.45],0.3139066450555085
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,43552,1092,0.95 [0.78-1.16],0.599854749596248
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",43739,614,0.85 [0.65-1.12],0.2462084541415699
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,43650,315,0.91 [0.63-1.32],0.6160832115663788
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,42114,105,1.65 [0.91-3.00],0.1006084149764086
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,42125,116,0.87 [0.47-1.60],0.6573736001122623
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,42104,95,1.00 [0.51-1.96],0.9970966233449138
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,43652,1192,0.84 [0.69-1.02],0.0722115681368155
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,42774,314,0.80 [0.55-1.16],0.2458265043625849
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,42539,79,1.88 [0.94-3.75],0.0754631914742633
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,43297,172,0.71 [0.43-1.18],0.1908917601873625
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,43581,456,0.93 [0.69-1.27],0.6614899454249004
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,42792,332,0.93 [0.65-1.34],0.7019563869916507
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,43525,190,0.94 [0.58-1.52],0.8118692868767179
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,43238,778,0.81 [0.64-1.03],0.0811329740749114
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,42933,233,1.06 [0.69-1.63],0.7897708352157041
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,41130,3701,1.09 [0.98-1.21],0.1177566024011165
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,43522,397,0.93 [0.67-1.29],0.6508443279638103
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,43775,258,1.27 [0.85-1.90],0.2410368162404864
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,42713,704,1.04 [0.81-1.33],0.7797386307201084
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,43242,117,0.71 [0.39-1.32],0.2784839061545988
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,43774,93,1.10 [0.56-2.16],0.7845912527813083
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,42152,143,0.79 [0.45-1.38],0.4069058099043018
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,42266,257,0.80 [0.53-1.21],0.2872263921990342
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,41923,199,0.65 [0.41-1.04],0.0701029814294169
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,42556,96,1.32 [0.67-2.57],0.4203359797606608
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",41836,112,0.56 [0.30-1.05],0.0716991479346888
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,42605,145,1.10 [0.64-1.88],0.73463294136367
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",42785,325,1.03 [0.72-1.47],0.8906824153163944
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,42218,209,1.16 [0.74-1.82],0.5124754622516444
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,41913,189,0.88 [0.54-1.45],0.6266363454249642
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,41858,134,0.87 [0.49-1.54],0.637297544824138
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,40432,3003,0.99 [0.88-1.12],0.9027784769568816
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,42134,125,0.70 [0.38-1.26],0.2325945249894451
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,43390,690,1.19 [0.93-1.53],0.163949174438573
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,42800,100,0.96 [0.50-1.84],0.9008109759047298
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),42966,266,1.02 [0.68-1.53],0.9192875336944564
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,43433,152,1.09 [0.64-1.85],0.7631918227298367
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,43733,200,1.25 [0.79-1.98],0.3461140229354565
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,43587,219,1.63 [1.06-2.50],0.0250184084714812
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,43390,109,1.56 [0.85-2.85],0.1533761231828483
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,43388,107,0.96 [0.51-1.83],0.9099943688015564
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,43634,1487,1.12 [0.94-1.32],0.2037385288304579
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,43210,1063,1.06 [0.87-1.30],0.5752706665118936
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,42357,210,0.83 [0.53-1.31],0.4228180127057287
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,42293,146,0.98 [0.57-1.70],0.9468131455978293
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Acute pharyngitis,43383,118,1.16 [0.63-2.12],0.640779692619801
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,43625,360,1.38 [0.98-1.94],0.0646443316590888
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,43370,105,2.20 [1.23-3.91],0.0075414386222796
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,All influenza,40440,199,1.80 [1.16-2.77],0.008141017219143
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),40436,195,1.84 [1.19-2.85],0.0058683486966572
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),30029,200,1.10 [0.68-1.78],0.6911233801252737
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Allergic rhinitis,43604,476,0.80 [0.59-1.10],0.1684772638567919
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",32413,3033,1.03 [0.91-1.16],0.6729411137529016
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",32814,2985,1.01 [0.90-1.15],0.8210962555926683
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),43120,239,1.39 [0.93-2.10],0.1118921080046726
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",40379,138,1.78 [1.06-2.99],0.0283436013124918
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Bronchiectasis,37919,589,1.24 [0.95-1.62],0.1083760092992487
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",37427,97,1.19 [0.62-2.30],0.5997681138154982
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,42082,4752,1.03 [0.94-1.14],0.5025298406562069
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",41470,123,0.85 [0.47-1.56],0.599162748347249
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,41603,256,0.93 [0.61-1.42],0.7411516650533914
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",43470,1998,1.05 [0.90-1.21],0.5395295557069992
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,41534,187,0.77 [0.47-1.26],0.3006023498404193
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,40283,8866,1.05 [0.98-1.13],0.1491917785643727
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",41975,628,0.93 [0.71-1.21],0.5773143330766211
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Early onset COPD,42025,553,0.89 [0.67-1.19],0.4465023640072534
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Emphysema,37868,538,1.09 [0.82-1.44],0.5490918586338738
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,41558,505,1.32 [0.99-1.76],0.0542063286006217
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,43423,3182,1.22 [1.09-1.37],0.0007145068077246
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,41615,562,1.36 [1.04-1.78],0.0253048092341328
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Later onset COPD,42062,1445,1.08 [0.91-1.28],0.3565127327855548
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,43789,516,1.20 [0.90-1.59],0.2153576026283877
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Nasal polyp,41539,192,0.90 [0.56-1.47],0.6814068927951487
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,43374,1628,1.22 [1.04-1.43],0.0169333480087727
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,43412,3353,1.24 [1.11-1.39],0.0001647794871828
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,42772,1425,0.87 [0.73-1.04],0.120945143413681
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Other pleural conditions,40144,85,0.61 [0.29-1.28],0.1892433596575621
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,43638,694,1.59 [1.25-2.01],0.0001375652836781
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,43631,2200,1.28 [1.12-1.47],0.000391920549902
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Pleural effusion,41706,1647,1.33 [1.13-1.56],0.0004648089115422
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Pleural plaque,40325,266,1.10 [0.73-1.64],0.6526122184808703
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",42997,2756,1.21 [1.07-1.37],0.0029598481477043
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,43675,402,1.35 [0.98-1.85],0.0658800052111046
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Pneumothorax,40268,209,0.84 [0.53-1.33],0.4509135888617249
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Pollen allergy,43775,407,0.82 [0.59-1.15],0.2554221650303075
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Pulmonary oedema,43053,109,2.85 [1.71-4.73],5.263337438797452e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,29921,92,1.28 [0.65-2.52],0.4670889377047369
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,43339,1593,1.20 [1.02-1.41],0.0311578765181798
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,41824,477,0.80 [0.59-1.10],0.1691875421623688
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Viral pneumonia,40649,408,1.32 [0.96-1.83],0.0895896373636183
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",43148,335,1.38 [0.97-1.96],0.0728450513261775
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,20214,187,1.09 [0.67-1.78],0.7273256195313077
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,31029,106,1.68 [0.90-3.13],0.1045598564444967
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Acute appendicitis,43532,240,1.03 [0.67-1.59],0.879840376255369
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Acute gastritis,33032,143,2.01 [1.20-3.35],0.0076589166779382
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,40688,314,1.22 [0.84-1.76],0.2979512515746328
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Acute peritonitis,43004,151,2.47 [1.55-3.92],0.0001425139886809
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,42307,127,1.50 [0.84-2.68],0.1738245775876881
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Barrett oesophagus,33632,743,1.14 [0.90-1.45],0.2851773087034115
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",40547,173,1.83 [1.15-2.91],0.0106585423393015
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",43102,173,1.81 [1.14-2.89],0.0124839043870742
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Cholecystitis,40714,340,1.02 [0.71-1.46],0.9130164643815792
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Cholelithiasis,42085,1711,1.20 [1.03-1.41],0.0221158516038153
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Chronic gastritis,33399,510,0.86 [0.64-1.15],0.3143031390440623
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,40458,84,1.08 [0.53-2.23],0.8315167070086972
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",43564,186,1.33 [0.83-2.13],0.2437952712481219
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Coeliac disease,41116,201,0.56 [0.35-0.91],0.0184809401677827
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Collagenous colitis,40943,135,1.21 [0.69-2.13],0.4979688288513982
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,43544,321,1.16 [0.80-1.68],0.4221364069401218
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Constipation,43380,2760,1.07 [0.95-1.21],0.2765705068470026
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Crohn disease,40960,152,1.08 [0.63-1.86],0.778461352480083
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",43205,108,0.77 [0.40-1.47],0.428016901446126
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,40949,141,1.04 [0.59-1.83],0.883796494680501
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Dental caries,42549,381,0.95 [0.68-1.34],0.7729522258269185
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,39316,3732,1.01 [0.91-1.13],0.8099873955144365
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of appendix,43593,301,0.94 [0.64-1.39],0.7703161153251639
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of liver,43604,1424,1.23 [1.04-1.47],0.0173978494693717
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",40125,7236,0.99 [0.92-1.07],0.8415581253006008
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",43098,930,0.96 [0.78-1.20],0.7469710653087127
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,43670,817,1.31 [1.05-1.65],0.0188733192338607
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,42360,192,0.94 [0.58-1.52],0.7965331852332105
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,42119,108,0.96 [0.50-1.81],0.888285245956202
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,43293,2378,1.16 [1.01-1.32],0.034109898940566
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of tongue,42129,183,1.15 [0.70-1.87],0.584439052290469
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",42772,2398,1.19 [1.04-1.36],0.010369416496624
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,36262,5339,1.14 [1.04-1.24],0.0055278024259442
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,33220,331,1.51 [1.06-2.14],0.0228591944136781
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",43660,263,1.19 [0.80-1.78],0.392032523599966
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,43670,90,0.93 [0.45-1.90],0.8431550417317246
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,42402,222,1.26 [0.81-1.95],0.3049978700501224
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,31171,248,1.09 [0.71-1.68],0.6887833282501341
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,33826,937,0.96 [0.77-1.19],0.7080285963691242
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Gastric ulcer,33494,605,0.83 [0.63-1.08],0.1667573611741825
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,37094,4205,1.01 [0.91-1.12],0.8062507464764856
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,33792,903,0.99 [0.79-1.23],0.8964795094651217
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,33907,13937,1.02 [0.96-1.08],0.5036140675191283
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,GI-bleeding,42847,1932,1.26 [1.09-1.46],0.0020598332795527
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,42272,104,1.02 [0.53-1.95],0.9626595595747244
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,32554,2110,1.03 [0.89-1.19],0.6910527115284281
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",42284,104,2.09 [1.14-3.83],0.0169891262287444
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Hernia,41030,5446,0.95 [0.86-1.04],0.2263902110286257
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Impacted teeth,43681,84,0.99 [0.47-2.07],0.9767791201070858
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Impaction of intestines,31019,96,2.28 [1.35-3.85],0.0021534586733523
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Inguinal hernia,37109,1525,0.74 [0.62-0.88],0.0006838084748496
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",35753,169,0.56 [0.33-0.94],0.0268299134059051
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,31082,159,0.97 [0.57-1.64],0.908749667964195
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,41156,241,0.66 [0.43-1.02],0.060188755852611
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,31857,934,1.00 [0.80-1.25],0.9871800923538084
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,43761,617,1.32 [1.01-1.71],0.040676910585782
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,42084,1276,1.38 [1.15-1.66],0.0004645315156697
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,42506,1698,1.30 [1.11-1.53],0.0009986332010018
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,33196,307,1.03 [0.70-1.50],0.8878449254348806
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Oesophagitis,33911,1022,1.00 [0.81-1.22],0.9658859086058356
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,43721,229,0.85 [0.55-1.33],0.478931227218425
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,35695,111,1.21 [0.65-2.25],0.5514858959253447
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,33217,2294,1.05 [0.92-1.21],0.4755769933877267
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,40843,469,1.22 [0.91-1.65],0.1906199387096945
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,40640,266,1.13 [0.75-1.69],0.5681510930051801
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,33893,2970,1.17 [1.03-1.32],0.0128515596832242
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,40387,9464,1.10 [1.03-1.18],0.0057280644363875
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,42100,351,0.80 [0.56-1.14],0.2123239114181787
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of liver,43341,1161,1.29 [1.06-1.56],0.0095540118954704
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,34027,1138,1.06 [0.87-1.29],0.5344615161458917
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,40620,246,1.48 [0.99-2.19],0.0545264969157721
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,43557,704,1.13 [0.88-1.45],0.3251820746713652
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,34485,1596,1.10 [0.93-1.30],0.2608330793032431
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,42873,1958,1.27 [1.09-1.47],0.0016544780358673
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,42467,299,0.93 [0.63-1.37],0.7191939916809005
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,33764,2841,1.09 [0.96-1.23],0.1844143966421431
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),36262,3373,1.09 [0.98-1.23],0.118307778515394
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,42351,171,0.97 [0.58-1.62],0.913168371126246
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,42297,1489,1.34 [1.14-1.59],0.0005718352278767
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",31501,578,1.19 [0.90-1.56],0.216963402981001
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,43652,107,1.00 [0.52-1.92],0.9891584628582444
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,31745,822,1.00 [0.79-1.26],0.9872541207478864
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",41176,261,1.01 [0.67-1.52],0.9708942566257002
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,43788,96,0.50 [0.25-0.99],0.0458090728622754
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,42173,190,0.77 [0.47-1.26],0.2983239945412956
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Toxic colitis,40901,93,1.84 [1.00-3.40],0.0514820167017892
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,33357,468,0.99 [0.73-1.34],0.9249263501556676
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,41083,275,1.31 [0.88-1.94],0.1813271318524291
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",41038,230,1.03 [0.66-1.60],0.910050194793064
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Umbilical hernia,36039,455,0.82 [0.60-1.12],0.2126214262210523
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,31218,295,1.48 [1.03-2.13],0.0323403097483131
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Ventral hernia,36019,435,1.35 [0.99-1.84],0.0606592026738466
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Volvulus,31056,133,0.42 [0.24-0.75],0.0033959998805937
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,43682,487,0.83 [0.61-1.12],0.2240157217554591
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,43270,133,1.38 [0.78-2.42],0.2663826760479268
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,40389,269,0.93 [0.62-1.40],0.7263841644895843
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,42715,1185,1.38 [1.14-1.66],0.0008913024642986
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",41828,298,1.38 [0.94-2.02],0.0970401005161398
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,40761,641,1.14 [0.88-1.47],0.3090526697713064
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,43288,465,1.20 [0.89-1.63],0.2317624845094229
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,43626,803,1.04 [0.82-1.32],0.7331123762792195
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,42907,84,0.83 [0.40-1.73],0.6231909161762978
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,41163,5368,1.00 [0.92-1.10],0.9192766156334272
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,43038,737,0.80 [0.63-1.02],0.0774458062497049
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,42813,512,0.77 [0.57-1.03],0.0800018545026944
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,43130,1600,1.35 [1.15-1.59],0.0002558141105083
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",43782,90,0.54 [0.27-1.10],0.0896176289215549
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,40228,108,0.93 [0.49-1.75],0.8157737854736117
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,42392,91,1.02 [0.51-2.02],0.9626248755521783
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,43270,447,1.29 [0.94-1.75],0.1105351310626703
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,40887,767,0.85 [0.67-1.08],0.1846813223592733
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,40234,114,0.48 [0.25-0.89],0.0204815521896518
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,43662,138,1.70 [0.99-2.90],0.052382009712045
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,41832,302,1.08 [0.74-1.57],0.701674001148499
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,43466,329,1.16 [0.81-1.66],0.4192542727020331
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,42922,99,1.03 [0.53-1.98],0.9411463998465736
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,40229,109,0.70 [0.37-1.33],0.2777347646982457
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,42836,2716,0.95 [0.84-1.08],0.4273587447987048
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",40952,832,0.85 [0.67-1.07],0.1699102445295825
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,40241,121,0.46 [0.25-0.84],0.0117420640231505
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,43662,525,1.03 [0.77-1.38],0.820286451058261
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,42941,118,1.23 [0.68-2.23],0.4992452446473687
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,43569,432,1.17 [0.85-1.61],0.3249178394065816
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,43725,530,0.83 [0.62-1.11],0.2173183387991372
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,40331,211,0.76 [0.48-1.21],0.253167982801576
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,40569,449,0.84 [0.61-1.16],0.2877192510062829
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,43708,513,0.84 [0.62-1.12],0.2356161979607773
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",40506,386,0.96 [0.69-1.34],0.8160564634979328
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,43755,231,1.39 [0.91-2.12],0.1290630555858095
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,37570,183,0.67 [0.41-1.10],0.1158630422713267
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,39857,9514,1.03 [0.96-1.10],0.4074123965487222
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,37463,7120,0.91 [0.84-0.99],0.0273435738565043
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,37517,130,0.98 [0.54-1.77],0.9483323620886546
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,38021,256,1.14 [0.75-1.73],0.5292975198896672
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,38063,298,1.29 [0.88-1.88],0.1878503654977793
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,43391,157,0.92 [0.54-1.56],0.7516872043017601
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",37931,166,0.72 [0.43-1.21],0.2116994261368199
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,32272,1929,0.83 [0.71-0.96],0.014485715242076
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",43578,324,0.90 [0.62-1.30],0.5701303743806331
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,38485,720,0.96 [0.75-1.23],0.7340265532923419
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,37021,12264,0.99 [0.93-1.05],0.7878403779726307
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,40456,200,1.43 [0.90-2.25],0.1263035923521438
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,37641,254,1.11 [0.74-1.68],0.6167401623359976
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,38364,977,0.94 [0.76-1.17],0.6050803697601361
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,42218,4453,0.99 [0.90-1.10],0.9048995161688144
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,37858,471,0.71 [0.52-0.97],0.0325154317283929
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,37769,382,0.95 [0.67-1.34],0.7673696144228902
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,37620,233,0.97 [0.62-1.50],0.876839976429843
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,42677,116,0.58 [0.31-1.08],0.087168808744399
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,33174,2831,0.91 [0.80-1.03],0.1350860019049467
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,31331,988,3.25 [2.73-3.85],2.4620309976429937e-41
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",43677,973,3.37 [2.84-4.01],2.599319481557853e-43
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,30473,130,0.73 [0.40-1.33],0.3108680699707915
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),30914,571,0.86 [0.65-1.15],0.311691319902487
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,37897,510,0.79 [0.59-1.07],0.125621684408934
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,31418,1075,0.95 [0.77-1.17],0.6213873705676327
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,37857,92,1.55 [0.81-2.93],0.1830089535717317
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,38820,1055,1.25 [1.03-1.53],0.0276346235832325
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,38271,506,0.82 [0.60-1.10],0.182494766523199
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,31344,1001,0.97 [0.78-1.20],0.7810833354038066
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,37512,125,1.15 [0.64-2.07],0.6407070235164023
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",37490,103,0.74 [0.38-1.43],0.3700971931220284
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,40378,122,2.09 [1.20-3.61],0.0086732887349167
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,43157,2901,1.01 [0.89-1.14],0.8867694650625966
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,42151,1895,0.95 [0.82-1.11],0.5076206103512826
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",43562,762,0.94 [0.74-1.20],0.6401573505573088
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,34531,4188,0.99 [0.89-1.09],0.8141176036777158
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,30448,105,0.93 [0.48-1.81],0.8297878225352263
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,37541,154,1.01 [0.59-1.73],0.9702182910890256
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,30431,88,1.53 [0.77-3.05],0.2245632060302534
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),30558,215,0.57 [0.36-0.91],0.0180293146452738
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,40670,414,1.18 [0.85-1.63],0.3201408193283964
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,40889,633,0.92 [0.70-1.20],0.5236197780000447
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,43759,166,0.90 [0.53-1.51],0.6815976324988612
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",40791,3026,1.00 [0.89-1.13],0.9790993471136394
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,37554,167,0.74 [0.44-1.26],0.2654452343506035
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),30583,240,0.92 [0.59-1.42],0.6951392316951559
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,38980,1215,0.93 [0.77-1.12],0.4483585670554618
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,33980,3637,1.02 [0.92-1.14],0.6931252928969508
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,42718,157,0.90 [0.53-1.52],0.6884452583564935
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,43779,125,1.39 [0.78-2.48],0.2700100966945392
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,37525,138,1.07 [0.61-1.87],0.8259814308650751
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",39487,2100,0.95 [0.83-1.10],0.5286236472001478
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,37535,148,1.26 [0.74-2.15],0.4019785570245815
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,33092,2749,1.02 [0.90-1.16],0.7082300303953726
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,40454,198,1.00 [0.62-1.61],0.997211855878197
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,37474,87,1.10 [0.54-2.26],0.793549978929066
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,38030,265,0.88 [0.59-1.33],0.5466203192206078
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,38305,918,1.20 [0.97-1.49],0.0950002211380211
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,43166,605,0.96 [0.73-1.25],0.7482737519068784
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,38729,964,1.10 [0.89-1.36],0.3723477858290344
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,43582,742,0.87 [0.68-1.11],0.2517586547434015
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,43772,88,1.05 [0.52-2.12],0.8844305370172689
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,37710,323,0.98 [0.68-1.42],0.9170974723121864
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,34679,1269,1.14 [0.95-1.37],0.1647242876908677
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,38362,975,0.91 [0.73-1.12],0.3734515233906936
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],37779,392,0.69 [0.49-0.97],0.03258136157769
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",30442,99,1.21 [0.62-2.35],0.5686602599230203
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,34541,4198,1.24 [1.12-1.37],3.25688091366836e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,31438,1095,1.02 [0.83-1.25],0.8606574840637989
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,42945,384,1.09 [0.78-1.52],0.6267990264732307
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",43700,107,1.11 [0.59-2.09],0.7557856159624637
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",40181,83,0.92 [0.45-1.88],0.8243785672234438
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,30471,128,1.41 [0.79-2.52],0.2496103518930878
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,37935,170,1.14 [0.69-1.89],0.5993991267247789
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,31115,772,0.93 [0.73-1.18],0.5481084590121601
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,37912,525,0.86 [0.64-1.15],0.302199512578734
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,38189,424,1.40 [1.02-1.91],0.0371650368685274
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,38071,306,0.88 [0.60-1.29],0.5159852700383957
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,34267,103,0.65 [0.33-1.28],0.2142124108082235
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",43780,96,1.08 [0.55-2.10],0.8282723436782277
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,38381,994,0.85 [0.68-1.05],0.1250479051689208
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],42728,167,0.58 [0.34-0.97],0.0384263427100022
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,41754,4367,0.93 [0.84-1.02],0.133912689713238
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",37612,225,1.05 [0.68-1.64],0.8197718519330383
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,38652,887,1.00 [0.80-1.25],0.9785327232335894
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,41376,389,0.94 [0.67-1.31],0.7003069684873382
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,38095,330,0.92 [0.64-1.33],0.672890151224155
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,40350,2585,1.05 [0.92-1.20],0.4432648715850358
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,39459,1694,1.10 [0.94-1.29],0.2549212963739674
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],37474,87,1.09 [0.54-2.23],0.8020673878106288
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,42811,250,1.15 [0.76-1.74],0.5115637637366353
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,37669,282,0.72 [0.48-1.08],0.1106581835882802
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,37520,133,0.91 [0.51-1.63],0.7544916494307856
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),30439,96,0.90 [0.45-1.78],0.7518406410369867
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,42224,2532,2.29 [2.04-2.57],1.5923012229432446e-43
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),17745,86,1.58 [0.79-3.16],0.1995560341043641
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,23115,100,0.92 [0.47-1.81],0.8158941830933553
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,43278,534,0.98 [0.73-1.30],0.8736863811057776
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,42888,144,1.25 [0.72-2.16],0.4218282522943659
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,41974,2282,3.96 [3.64-4.32],9.599453538830412e-218
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,43472,104,3.62 [2.63-4.98],3.5699121794181725e-15
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,43429,488,1.43 [1.07-1.91],0.01576520747039
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Cystitis,38700,392,1.03 [0.74-1.45],0.8407697731290473
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Dialysis,39804,112,3.54 [2.70-4.64],5.511497180751884e-20
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,19048,2777,1.01 [0.89-1.15],0.827438492671007
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23297,282,0.93 [0.63-1.39],0.7387008881929275
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Endometriosis,17808,149,1.59 [0.94-2.71],0.0848419494347118
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",17994,335,0.79 [0.54-1.16],0.226707111228757
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18515,856,0.92 [0.73-1.16],0.4835369660122264
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,36589,8920,1.23 [1.15-1.32],1.0592597483202905e-08
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,43490,122,4.33 [2.90-6.48],9.588341251261818e-13
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Hydrocele,16440,169,0.53 [0.32-0.89],0.0156279036877099
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,39640,469,1.66 [1.23-2.25],0.0009834794738905
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,18448,2177,1.06 [0.92-1.23],0.3940829749796067
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23229,344,1.42 [1.01-2.01],0.0456072695987943
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),16465,194,1.10 [0.68-1.77],0.6979930781371688
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Irregular menses,23311,107,0.86 [0.44-1.66],0.655361007673935
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,17921,262,0.77 [0.50-1.17],0.2202826852542544
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,38431,123,0.89 [0.49-1.63],0.7133084782056476
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,19753,2094,1.07 [0.93-1.24],0.334414856022998
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,16371,100,0.61 [0.31-1.18],0.1430185977911873
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,17780,121,1.27 [0.70-2.31],0.4346317180263581
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",43794,109,1.05 [0.56-1.97],0.8736934694578183
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",43792,115,1.22 [0.67-2.22],0.5228846285173604
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,42027,3719,1.10 [0.98-1.22],0.0925259596245033
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,39516,1208,0.98 [0.81-1.19],0.8450950964387347
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,23114,99,0.60 [0.30-1.19],0.1428035070706023
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,43701,760,2.09 [1.69-2.60],1.9796267122002648e-11
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,16529,258,0.96 [0.63-1.46],0.8496005161122386
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,16507,236,1.06 [0.69-1.65],0.779203068336498
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,16459,188,1.25 [0.78-2.02],0.3541222904999892
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,43745,118,1.78 [1.01-3.13],0.0464273400508656
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,41152,2844,1.16 [1.03-1.31],0.0166299678306394
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,23064,179,1.72 [1.07-2.74],0.0241507445555057
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,17792,133,1.18 [0.66-2.09],0.5756865086868839
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",17994,335,1.14 [0.79-1.64],0.4806692345235008
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,17762,103,0.57 [0.29-1.11],0.0993812162170384
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,17841,182,0.83 [0.50-1.36],0.4611751717857926
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,39720,549,1.86 [1.42-2.45],8.132110755290452e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,43193,252,2.84 [2.03-3.97],1.0889452398007512e-09
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,17911,252,0.90 [0.59-1.38],0.6270771280994027
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,17749,90,0.80 [0.39-1.65],0.552086426093714
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18206,547,1.35 [1.02-1.78],0.0367272011048112
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,17798,139,1.31 [0.76-2.26],0.331884059445066
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18164,505,1.48 [1.11-1.97],0.0069085231701128
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,43453,85,2.50 [1.32-4.73],0.0049756999471059
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",16492,221,1.16 [0.74-1.82],0.5086700496295025
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,43436,4265,2.45 [2.24-2.67],2.8326595506186986e-89
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",39370,199,2.58 [1.71-3.88],5.639052179845186e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,39892,200,4.66 [3.56-6.10],4.4155524431968886e-29
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,42837,93,1.04 [0.52-2.08],0.9205280057910354
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,38677,369,1.24 [0.88-1.75],0.2190465636635824
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,43412,668,1.00 [0.77-1.29],0.9897009728672086
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,17778,119,1.05 [0.57-1.93],0.8826853063959602
